Pierre Fontana

An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN.

Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects.

P2Y12 H2 haplotype is associated with peripheral arterial disease: a case-control study.

Skin necrosis is a clinical manifestation of low-molecular weight heparin-induced thrombocytopenia.

The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers.

Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature.

[Study of primary hemostasis in vitro with the Platelet Function Analyzer (PFA-100)].

The thrombomodulin-1208/-1209delTT gene promoter polymorphism does not affect basal or LPS-dependent monocyte TM mRNA transcription in healthy volunteers.

Physiological plasma Gas6 levels do not influence platelet aggregation.

Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy.

Identification of functional polymorphisms of the thromboxane A2 receptor gene in healthy volunteers.

Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19*2 allele on clopidogrel responsiveness.

Laboratory-defined aspirin resistance and recurrent cardiovascular events.

[Frequently asked questions on clopidogrel treatment: indications, resistance, and biological evaluation in vascular patients].

Aspirin response variability assessed with the PFA-100 device.

Intercellular communication in atherosclerosis.

[A reference to know: the 2008 Chest Supplement on antithrombotic agents].

[The new antithrombotics in 2009].

Cell-derived microparticles in haemostasis and vascular medicine.

Acute coronary syndrome and its antithrombotic treatment: focus on aspirin and clopidogrel resistance.

No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro.

Diagnosis of mild bleeding disorders.

Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.

[Evaluating the biological efficacy of clopidogrel: genotype or phenotype?].

Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and management.

Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients.

Connexin 37 limits thrombus propensity by downregulating platelet reactivity.

Platelet proteomics.

[Monitoring of heparins and of anticoagulants].

Prevalence of poor biological response to clopidogrel: a systematic review.

Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study.

Aspirin for venous thromboembolism prevention and treatment: a renewal?

Tailored Thienopyridine therapy: no urgency for CYP2C19 genotyping.

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.

[Invasive procedures and long-term anti-coagulation: to bridge or not to bridge?].

[Antiplatelet agents and older patients: which drugs and what evidence?].

Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A.

Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism.

How to manage prasugrel and ticagrelor in daily practice.

Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules.

[Aspirin: once or twice a day?].

Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia.

Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: an observational study on cord blood.

Suspicion of heparin-induced thrombocytopenia in internal medicine: How appropriate is the ordering of anti-PF4/heparin antibody testing?

Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins.

Antiplatelet drugs and platelet reactivity: is it time to halt clinical research on tailored strategies?

Direct oral anticoagulants: efficacy and safety in patient subgroups.

[Last generation anti-thrombotic drugs and cerebral hemorrhage ].

Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study.

Lack of Effect of Platelet Transfusions and Desmopressin on Intracranial Bleeding in a Patient Receiving Ticagrelor.

A focus on the role of platelets in liver regeneration: Do platelet-endothelial cell interactions initiate the regenerative process?

Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review.

Aspirin response: Differences in serum thromboxane B2 levels between clinical studies.

Reply to: "The role of platelets in liver regeneration - What don't we know?".

Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data.

Modulation of osteoblast behavior on TiNxOy coatings by altering the N/O stoichiometry while maintaining a high thrombogenic potential.

Pharmacogenomics of Oral Antithrombotic Drugs.

New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach.

[News in angiology and hemostasis].

Direct oral anticoagulants: a guide for daily practice.

TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke.

PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients.

Genetic testing to identify women at risk of venous thromboembolism with contraceptive pills: Evidence or hope-based tool ?

Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.

Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled study.

Correction of prasugrel-related bleeding by prophylactic transfusion of human platelets in a rabbit model.

Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015.

Authors' reply to the technical comment from Joelle Michaud and Goranka Tanackovic.

Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect.

Pannexin1 Single Nucleotide Polymorphism and Platelet Reactivity in a Cohort of Cardiovascular Patients.

Impact of rivaroxaban on point-of-care assays.